Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma in young persons.

G M Hewell, R Alexanian

    Annals of Internal Medicine
    |April 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Multiple myeloma, a rare cancer, was diagnosed in three young men aged 17-22. Initial diagnoses were doubted due to their young age, highlighting the need for broader consideration of this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Value of novel agents and intensive therapy for patients with multiple myeloma.

    Bone marrow transplantation·2013
    Same author

    Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD).

    Hematology (Amsterdam, Netherlands)·2010
    Same author

    CR represents an early index of potential long survival in multiple myeloma.

    Bone marrow transplantation·2009
    Same author

    Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.

    Hematology (Amsterdam, Netherlands)·2007
    Same author

    International uniform response criteria for multiple myeloma.

    Leukemia·2006
    Same author

    Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Internal Medicine

    Background:

    • Multiple myeloma is a plasma cell malignancy typically affecting older adults.
    • Diagnosis in adolescents and young adults is uncommon and often delayed.
    • This case series addresses a diagnostic challenge in a pediatric and young adult population.

    Purpose of the Study:

    • To report the first well-documented cases of multiple myeloma in a group of very young patients.
    • To highlight the diagnostic difficulties and delayed recognition of multiple myeloma in adolescents and young adults.
    • To emphasize the importance of considering multiple myeloma in the differential diagnosis of unexplained symptoms in young individuals.

    Main Methods:

    • Case series review of three young male patients diagnosed with multiple myeloma.

    Related Experiment Videos

  • Clinical presentation, diagnostic workup, and initial treatment were analyzed.
  • Electrophoretic studies were crucial for confirming the diagnosis.

    • Main Results:

    • Three male patients aged 17–22 years were diagnosed with multiple myeloma.
    • Initial diagnostic considerations were challenged due to the patients' young age.
    • Disease was not advanced at the time of diagnosis in these cases.
    • Electrophoretic studies confirmed the diagnosis in all three patients.

    Conclusions:

    • Multiple myeloma can occur in young individuals, challenging traditional diagnostic assumptions.
    • Delayed diagnosis is common in this age group due to rarity and atypical presentation.
    • Electrophoresis is a key diagnostic tool for identifying multiple myeloma, regardless of patient age.